REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q/A Sep 23, 2024 10-Q/A
10-K/A Sep 23, 2024 10-K/A
CORRESP Sep 23, 2024
424B3 Sep 13, 2024 424B3
UPLOAD Sep 13, 2024
EFFECT Sep 12, 2024
CORRESP Sep 10, 2024
UPLOAD Sep 9, 2024
S-3 Sep 3, 2024 S-3
8-K Aug 26, 2024 8-K
8-K Aug 19, 2024 8-K
8-K Aug 9, 2024 8-K
10-Q Aug 9, 2024 10-Q
8-K Aug 2, 2024 8-K
EFFECT Jul 26, 2024
CORRESP Jul 23, 2024
UPLOAD Jul 23, 2024
S-3 Jul 19, 2024 S-3
8-K Jun 24, 2024 8-K
S-8 Jun 18, 2024 S-8
8-K May 16, 2024 8-K
8-K May 10, 2024 8-K
10-Q May 10, 2024 10-Q
DEF 14A Apr 16, 2024 DEF 14A
PRE 14A Apr 5, 2024 PRE 14A
← Newer Page 6 of 16 · 387 filings Older →